| P2093 | author name string | Po-Lin Kuo | |
| | Chia-Yen Dai | |
| | Meng-Hsuan Hsieh | |
| | Ching-I Huang | |
| | Chung-Feng Huang | |
| | Jee-Fu Huang | |
| | Ming-Lun Yeh | |
| | Ming-Lung Yu | |
| | Ming-Yen Hsieh | |
| | Wan-Long Chuang | |
| | Zu-Yau Lin | |
| | Shinn-Cherng Chen | |
| | Hsing-Tao Kuo | |
| P2860 | cites work | Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study | Q28608449 |
| | Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: Prevalence, racial/ethnic differences, and viral interactions | Q29036593 |
| | Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients | Q34577157 |
| | Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment | Q37132382 |
| | Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. | Q37207070 |
| | Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy | Q37328172 |
| | Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. | Q37709943 |
| | Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance | Q40350424 |
| | Role of hepatitis C virus in dual and triple hepatitis virus infection | Q40413238 |
| | Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C. | Q40446411 |
| | Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection | Q40946687 |
| | The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients | Q41654105 |
| | Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication | Q42232663 |
| | Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy | Q42250183 |
| | Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection | Q42285091 |
| | Viral hepatitis infections in southern Taiwan: a multicenter community-based study | Q42908922 |
| | Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Q42983894 |
| | Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. | Q42989324 |
| | Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection | Q43032316 |
| | Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients | Q43033484 |
| | Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection | Q43035211 |
| | A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. | Q43035978 |
| | Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin | Q43038052 |
| | Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients | Q43041735 |
| | Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1. | Q43047354 |
| | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study | Q43687289 |
| | Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy | Q50559084 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eradication of infectious diseases | Q1347969 |
| P304 | page(s) | 12240-12249 | |
| P577 | publication date | 2018-01-13 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. | |
| P478 | volume | 9 | |